FLUOROURACIL injection
for intravenous use Initial U.S. Approval: 1962

Fluorouracil is a nucleoside metabolic inhibitor indicated for the treatment of patients with • Adenocarcinoma of the Colon and Rectum
• Adenocarcinoma of the Breast • Gastric Adenocarcinoma • Pancreatic Adenocarcinoma

Facts about FLUOROURACIL injection

Approval Date: 1962
Proprietary Name: On Request
Active Ingredient(s): FLUOROURACIL injection
Dosage Forms And Strengths: Injection: 2.5 g in a 50 mL vial in a pharmacy bulk package
Company: Spectrum Pharmaceuticals, Inc.
Current indications: • Adenocarcinoma of the Colon and Rectum • Adenocarcinoma of the Breast • Gastric Adenocarcinoma • Pancreatic Adenocarcinoma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import FLUOROURACIL injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.